机构

• 上海药物研究所 [7]
• 合肥物质科学研究院 [5]
• 计算技术研究所 [1]
• 中国科学院大学 [1]

采集方式

• OAI收割 [13]
• iSwitch采集 [1]

内容类型

• 期刊论文 [14]

发表日期

• 2022 [3]
• 2021 [2]
• 2020 [3]
• 2019 [1]
• 2018 [1]
• 2017 [1]
• 更多

学科主题

筛选

浏览/检索结果: 共14条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 The effect of EGFR-TKIs on survival in advanced non-small-cell lung cancer with EGFR mutations: A real-world study 期刊论文  OAI收割 CANCER MEDICINE, 2022 作者:  Yu, Xiaoqing;  Si, Jinfei;  Wei, Jingwen;  Wang, Yanling;  Sun, Yan   |  收藏  |  浏览/下载：87/0  |  提交时间：2022/12/23 EGFR-TKIs  non-small cell lung cancer (NSCLC)  real-world study  survival outcome   Impact of clinical and molecular features on efficacy and outcome of patients with non-small cell lung cancer receiving second-line osimertinib 期刊论文  OAI收割 BMC CANCER, 2022, 卷号: 22 作者:  Jin, Ying;  Lin, Chen;  Shi, Xun;  He, Qiong;  Yan, Junrong   |  收藏  |  浏览/下载：71/0  |  提交时间：2022/12/23 Clinical and molecular features  Efficacy and outcome  EGFR T790M mutation  Non-small-cell lung cancer  Osimertinib   Disclosing Potential Key Genes, Therapeutic Targets and Agents for Non-Small Cell Lung Cancer: Evidence from Integrative Bioinformatics Analysis 期刊论文  OAI收割 VACCINES, 2022, 卷号: 10, 期号: 5, 页码: 20 作者:  Mosharaf, Md Parvez;  Reza, Md Selim;  Gov, Esra;  Mahumud, Rashidul Alam;  Mollah, Md Nurul Haque   |  收藏  |  浏览/下载：16/0  |  提交时间：2022/12/07 non-small cell lung cancer  gene expression profiles  molecular signatures  therapeutic targets and agents  integrated bioinformatics approaches   Clinical outcomes of lung adenocarcinoma patients harboring uncommon epidermal growth factor receptor (EGFR) mutations treated with EGFR-tyrosine kinase inhibitors (TKIs) 期刊论文  OAI收割 ANNALS OF PALLIATIVE MEDICINE, 2021 作者:  Si, Jinfei;  Gu, Xiaodong;  Wang, Wenxian;  Ying, Shenpeng;  Song, Zhengbo   |  收藏  |  浏览/下载：78/0  |  提交时间：2022/02/14 Epidermal growth factor receptor (EGFR)  uncommon mutation  compound mutation  double uncommon mutation  lung adenocarcinoma (lung AC)   Efficacy and Resistance of Afatinib in Chinese Non-Small Cell Lung Cancer Patients With HER2 Alterations: A Multicenter Retrospective Study 期刊论文  OAI收割 FRONTIERS IN ONCOLOGY, 2021, 卷号: 11 作者:  Song, Zhengbo;  Lv, Dongqing;  Chen, Shiqing;  Huang, Jianhui;  Wang, Liping   |  收藏  |  浏览/下载：51/0  |  提交时间：2021/06/21 non-small cell lung cancer (NSCLC)  HER2  afatinib  efficacy  resistance   Simultaneous determination of sutetinib and its active metabolite sutetinibN-oxide in human plasma by liquid chromatography-tandem mass spectrometry: Evaluation of plasma stability 期刊论文  OAI收割 BIOMEDICAL CHROMATOGRAPHY, 2020, 页码: 9 作者:  Qiu, Yanan;  Tang, Chongzhuang;  Li, Ranran;  Cao, Sumin;  Zhang, Yuqiang   |  收藏  |  浏览/下载：39/0  |  提交时间：2020/12/24 LC-MS  MS  N-oxide  stability  sutetinib   EGFR exon 20 insertion mutations in non-small cell lung cancer 期刊论文  OAI收割 TRANSLATIONAL CANCER RESEARCH, 2020, 卷号: 9 作者:  Wang, Fenfang;  Li, Chenghui;  Wu, Qihuan;  Lu, Hongyang   |  收藏  |  浏览/下载：54/0  |  提交时间：2020/11/26 EGFR exon 20 insertion mutations  non-small cell lung cancer (NSCLC)  EGFR-TKIs  structural features  clinical features  treatment  prognosis   Inhibition of Tumor Lymphangiogenesis is an Important Part that EGFR-TKIs Play in the Treatment of NSCLC 期刊论文  OAI收割 JOURNAL OF CANCER, 2020, 卷号: 11, 期号: 1, 页码: 241-250 作者:  Zhang, Yan;  Yang, Xinying;  Liu, Hongchun;  Cai, Minghui;  Yang Shentu   |  收藏  |  浏览/下载：64/0  |  提交时间：2020/07/01 EGFR-TKIs  NSCLC  lymphangiogenesis  JAK/STAT3  LYVE-1   Synthesis and Biological Evaluation of Oxopyrido[2,3-d] Pyrimidine-7-ones Derivatives as Covalent L85812/T790M Mutant Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors 期刊论文  OAI收割 LETTERS IN DRUG DESIGN & DISCOVERY, 2019, 卷号: 16, 期号: 8, 页码: 826-834 作者:  Niu, Ao;  Wang, Yang;  Yang, Yushe;  Wei, Jianhai;  Ding, Jian   |  收藏  |  浏览/下载：67/0  |  提交时间：2020/07/01 Non-small cell lung cancer  irreversible inhibitors  EGFR(T79014)( )mutant  anti-tumor  xenograft model  cell proliferation   Discovery of novel 2,4-diarylaminopyrimidine derivatives as potent and selective epidermal growth factor receptor (EGFR) inhibitors against L858R/T790M resistance mutation 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 152, 页码: 298-306 作者:  Yan, Qi;  Chen, Yuzhe;  Tang, Baiyou;  Xiao, Qiang;  Qu, Rong   |  收藏  |  浏览/下载：76/0  |  提交时间：2019/01/08 EGFR inhibitors  Pyrimidine derivatives  Mutant selective inhibitors  AZD9291  T790M